| Literature DB >> 32730221 |
Hana Moon1, Geon Ho Lee1.
Abstract
BACKGROUND: In South Korea, the number of coronavirus disease (COVID-19) cases has declined rapidly and much sooner than in other countries. South Korea is one of the most digitalized countries in the world, and YouTube may have served as a rapid delivery mechanism for increasing public awareness of COVID-19. Thus, the platform may have helped the South Korean public fight the spread of the disease.Entities:
Keywords: COVID-19; YouTube; consumer health information; health communication; health education; infectious disease outbreaks; infodemic; infodemiology; infoveillance; internet; misinformation; multimedia; public health surveillance; social media
Mesh:
Year: 2020 PMID: 32730221 PMCID: PMC7425748 DOI: 10.2196/20775
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Data collection flow.
The characteristics of misleading and useful videos.a
| Variablesb | Misleading videos | Useful videos | Total | ||
| Videos, n (%) | 39 (37.14) | 66 (62.86) | 105 (100) | N/Ac | |
|
| |||||
|
| Views | 972,020 (800,267) | 1,344,307 (1,537,507) | 1,206,029 (1,320,654) | .11 |
|
| Likes | 18,266 (12,772) | 12,389 (13,519) | 14572 (13,490) | .03 |
|
| Dislikes | 774 (656) | 545 (622) | 630 (641) | .08 |
|
| Comments | 2203 (1532) | 3224 (2983) | 2845 (2581) | .02 |
|
| Days | 79 (22) | 70 (27) | 73 (26) | .09 |
|
| Length (seconds) | 795 (1046) | 405 (340) | 550 (713) | .03 |
|
| VPId | 67,708 (159,243) | 129,469 (443,911) | 106,529 (365,137) | .31 |
|
| |||||
|
| Independent users | 32 (68.09) | 15 (31.91) | 47 (44.76) | N/A |
|
| News agencies | 4 (10.26) | 35 (89.74) | 39 (37.14) | N/A |
|
| Health care professionals | 3 (27.27) | 8 (72.73) | 11 (10.48) | N/A |
|
| Government agencies | 0 (0.00) | 8 (100) | 8 (7.62) | N/A |
aStudent t test was used to compare misleading and useful videos.
bContinuous variables were presented as mean (SD), and categorical variables were presented as n (%).
cN/A: not applicable.
dVPI: video power index.
Video metrics, reliability, overall quality, title–content consistency, and content of the useful videos by source.
| Variablesa | Independent users | News agencies | Health care professionals | Government agencies | Total | |||
| Videos, n (%) | 15 (22.73) | 35 (55.03) | 8 (12.12) | 8 (12.12) | 66 (100.00) | N/Ac | ||
|
| ||||||||
|
| Views | 744,824 (553,149-1,050,672) | 906,731 (768,863-1,282,426) | 928,563 (768,613-1,083,527) | 2,418,742 (856,649-3,896,445) | 888,772 (726,536-1,292,581) | .04 | |
|
| Likes | 9643 (5063-18,041) | 7523 (4727-12,831) | 20,874 (14,977-27,702) | 1037 (157-15,169) | 9756 (4598-16,432) | .005 | |
|
| Dislikes | 348 (190-494) | 305 (195-469) | 789 (396-894) | 104 (19-1280) | 355 (179-698) | .10 | |
|
| Comments | 1251 (779-2516) | 2938 (1810-5570) | 2031 (1055-3242) | 179 (35-3921) | 2377 (1251-4151) | .03 | |
|
| Days | 56 (32-84) | 85 (47-98) | 72 (67-94) | 74 (54-82) | 75 (49-96) | .22 | |
|
| Length (seconds) | 422 (246-518) | 207 (165-536) | 791 (371-822) | 41 (36-176) | 249 (162-602) | .002 | |
|
| VPId | 15,689 (5786-112,775) | 22,326 (4568-50,043) | 33,709 (16,773-54,613) | 9652 (755-208,260) | 18,092 (5780-56,760) | .54 | |
|
| ||||||||
|
| DISCERN | 2.0 (1.0-3.0) | 4.0 (4.0-5.0) | 4.5 (3.0-5.0) | 5.0 (5.0-5.0) | 4.0 (3.0-5.0) | <.001 | |
|
| JAMASe | 2.0 (1.5-2.0) | 3.0 (3.0-4.0) | 2.5 (2.0-3.0) | 4.0 (4.0-4.0) | 3.0 (2.0-4.0) | <.001 | |
|
| ||||||||
|
| GQSf | 2.0 (1.5-2.0) | 3.0 (2.0-3.0) | 3.5 (2.5-4.5) | 4.0 (3.0-4.5) | 3.0 (2.0-3.0) | <.001 | |
|
| ||||||||
|
| TCCIg | 3.0 (3.0-4.0) | 5.0 (4.0-5.0) | 3.0 (2.0-4.0) | 5.0 (5.0-5.0) | 5.0 (3.0-5.0) | <.001 | |
|
| ||||||||
|
|
| |||||||
|
|
| Prevalence | 10 (66.67) | 27 (77.14) | 5 (62.50) | 2 (25) | 44 (66.67) | N/A |
|
|
| Transmission and precautionary measures | 11 (73.33) | 23 (65.71) | 7 (87.50) | 8 (100) | 49 (74.24) | N/A |
|
|
| Signs and symptoms | 4 (26.67) | 17 (48.57) | 3 (37.50) | 7 (87.50) | 31 (46.97) | N/A |
|
|
| Testing | 7 (46.67) | 15 (42.86) | 4 (50) | 4 (50) | 30 (45.45) | N/A |
|
|
| Treatment and outcome | 3 (20) | 16 (45.71) | 4 (50) | 1 (12.50) | 24 (36.36) | N/A |
|
| Total score of MICIh, median (IQR) | 5.0 (3.0-7.0) | 5.0 (3.5-6.5) | 7.0 (2.5-8.0) | 5.0 (5.0-9.0) | 5.0 (3.00-7.0) | .77 | |
|
|
| |||||||
|
|
| Prevalence | 1.0 (0.0-1.0) | 1.0 (1.0-1.0) | 1.0 (0.0-2.5) | 0.0 (0.0-0.5) | 1.0 (0.0-1.0) | .18 |
|
|
| Transmission and precautionary measures | 2.0 (0.5-3.0) | 2.0 (0.0-3.0) | 2.5 (1.5-3.5) | 3.0 (2.0-3.5) | 2.0 (0.0-3.0) | .23 |
|
|
| Signs and symptoms | 0.0 (0.0-1.0) | 0.0 (0.0-2.0) | 0.0 (0.0-2.0) | 2.0 (2.0-2.5) | 0.0 (0.0-2.0) | .03 |
|
|
| Testing | 0.0 (0.0-2.0) | 0.0 (0.0-2.0) | 0.5 (0.0-1.0) | 1.0 (0.0-2.5) | 0.0 (0.0-2.0) | .86 |
|
|
| Treatment and outcome | 0.0 (0.0-0.0) | 0.0 (0.0-2.0) | 0.5 (0.0-2.0) | 0.0 (0.0-0.0) | 0.0 (0.0-1.0) | .23 |
aContinuous variables were presented as median (IQR), and categorical variables were presented as n (%).
bKruskal-Wallis tests were used to calculate P values.
cN/A: not applicable.
dVPI: video power index.
eJAMAS: Journal of the American Medical Association Score.
fGQS: global quality score.
gTCCI: title–content consistency index.
hMICI: medical information and content index.